FPH Share Price

Open 8.30 Change Price %
High 8.31 1 Day 0.01 0.12
Low 8.23 1 Week -0.30 -3.50
Close 8.26 1 Month -0.34 -3.95
Volume 690913 1 Year -0.12 -1.43
52 Week High 10.93
52 Week Low 8.13
FPH Important Levels
Resistance 2 8.33
Resistance 1 8.30
Pivot 8.27
Support 1 8.22
Support 2 8.19
NZE NewZealand Most Active Stocks
NPX 5.45 0.55%
NPX 5.45 0.55%
NPX 5.45 0.55%
TEL 2.87 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
DIL 7.03 0.00%
DIL 7.03 0.00%
ATM 2.41 -1.23%
More..
NZE NewZealand Top Gainers Stocks
TWR 0.84 3.70%
TWR 0.84 3.70%
TWR 0.84 3.70%
OIC 0.94 3.30%
PEB 0.55 1.85%
PEB 0.55 1.85%
PEB 0.55 1.85%
FBU 10.73 1.71%
FBU 10.73 1.71%
KMD 1.93 1.58%
More..
NZE NewZealand Top Losers Stocks
SLG 0.09 -10.00%
SLG 0.09 -10.00%
SLG 0.09 -10.00%
SLG 0.09 -10.00%
WDT 0.16 -5.88%
SCY 0.70 -2.78%
CDI 0.70 -2.78%
CDI 0.70 -2.78%
CDI 0.70 -2.78%
CDI 0.70 -2.78%
More..

Fisher & Paykel Healthcar (NZE: FPH)

FPH Technical Analysis 5
As on 9th Dec 2016 FPH Share Price closed @ 8.26 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 9.55 & Strong Sell for SHORT-TERM with Stoploss of 9.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
FPH Target for December
1st Target up-side 8.82
2nd Target up-side 9.26
3rd Target up-side 9.71
1st Target down-side 7.54
2nd Target down-side 7.1
3rd Target down-side 6.65
FPH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.fphcare.com
FPH Address
FPH
15 Maurice Paykel Place
East Tamaki
Auckland, 2013
New Zealand
Phone: 64 9 574 0100
Fax: 64 9 574 0158
Interactive Technical Analysis Chart Fisher & Paykel Healthcar ( FPH NZE NewZealand )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Fisher & Paykel Healthcar
FPH Business Profile
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems for use in respiratory and acute care, and the treatment of obstructive sleep apnea (OSA). The company offers a range of continuous positive airway pressure (CPAP) devices, masks, and humidifiers, which comprise nasal, full face, and oral masks. It also provides respiratory humidifiers, single-use and reusable chambers and breathing circuits and accessories designed to humidify and deliver the gases that a patient receives during mechanical ventilation, non-invasive ventilation, oxygen therapy, humidity therapy and laparoscopic surgery; and T-piece resuscitation, invasive ventilation, CPAP therapy, nasal high flow, and low flow therapy solutions for infants. In addition, the company offers humidification systems for preventing unnecessary cellular damage by protecting tissue against the harmful effects of cold, dry carbon dioxide2; and protecting the peritoneum against damage caused by cold, dry surgical gas during laparoscopic surgery. Fisher & Paykel Healthcare Corporation Limited sells its products through its distribution subsidiaries, third party distributors, and original equipment manufacturers in New Zealand, North America, Europe, and the Asia-Pacific. The company was founded in 1934 and is headquartered in Auckland, New Zealand.